financetom
Business
financetom
/
Business
/
Market Chatter: Ares Management Leads $1.8 Billion Debt Package for Genstar Capital-AffiniPay Deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Ares Management Leads $1.8 Billion Debt Package for Genstar Capital-AffiniPay Deal
Jul 19, 2024 12:59 PM

03:38 PM EDT, 07/19/2024 (MT Newswires) -- Ares Management ( ARES ) and other lenders, including Oak Hill Advisors, have agreed to provide around $1.8 billion debt package to support Genstar Capital's acquisition of a stake in AffiniPay, Bloomberg reported Friday, citing people with knowledge of the matter.

The financing reportedly includes a $1.2 billion term loan and $300 million of preferred equity. Additionally, the package offers a $200 million delayed draw term loan and a $100 million revolving credit facility, the people told Bloomberg.

The stake purchase, expected to close in Q3, will give Genstar about 50% stake in AffiniPay, the people told Bloomberg.

Ares, Genstar, Oak Hill Advisors and AffiniPay did not immediately respond to MT Newswires' requests for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 148.15, Change: +0.76, Percent Change: +0.51

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bioventus' Two Nerve Stimulation Devices Get FDA 510(k) Clearance; Shares Rise
Bioventus' Two Nerve Stimulation Devices Get FDA 510(k) Clearance; Shares Rise
Jul 30, 2025
10:31 AM EDT, 07/30/2025 (MT Newswires) -- Bioventus ( BVS ) said Wednesday that the US Food and Drug Administration has given 510(k) clearances for TalisMann and StimTrial, the company's peripheral nerve stimulation, or PNS, devices for chronic pain management. TalisMann targets deeper, larger nerves and is designed to provide long-term relief from chronic nerve pain. StimTrial allows doctors to...
Ermenegildo Zegna Shares Fall After Q2 Revenue Declines
Ermenegildo Zegna Shares Fall After Q2 Revenue Declines
Jul 30, 2025
10:36 AM EDT, 07/30/2025 (MT Newswires) -- Ermenegildo Zegna ( ZGN ) shares were down 1.8% in recent Wednesday trading after it reported Q2 revenue of 468.9 million euros ($537.8 million), down from 497.0 million euros a year earlier. One analyst polled by FactSet expected 468.9 million euros. Price: 8.58, Change: -0.16, Percent Change: -1.83 ...
America's Car-Mart Delays Annual 10-K Filing
America's Car-Mart Delays Annual 10-K Filing
Jul 30, 2025
10:33 AM EDT, 07/30/2025 (MT Newswires) -- America's Car-Mart (CRMT) said Wednesday that it was unable to file its Form 10-K for the fiscal year ended April 30 within the extension period that lapsed Tuesday. The company said it is working to complete certain omitted disclosures that will be included in the filing as soon as reasonably practicable. America's Car-Mart...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved